Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
Merit Medical Systems (NASDAQ: MMSI) has announced it will release its Q1 2025 financial results on April 24, 2025, after market close. The company will host an investor conference call the same day at 5:00 p.m. Eastern time.
Founded in 1987, Merit Medical Systems is a global manufacturer and marketer of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, with focus on cardiology, radiology, oncology, critical care, and endoscopy. The company maintains a global presence with over 800 sales and clinical support professionals and approximately 7,300 employees worldwide.
Merit Medical Systems (NASDAQ: MMSI) ha annunciato che rilascerà i risultati finanziari del primo trimestre del 2025 il 24 aprile 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica per gli investitori lo stesso giorno alle 17:00, ora orientale.
Fondata nel 1987, Merit Medical Systems è un produttore e commercializzatore globale di dispositivi medici proprietari utilizzati in procedure interventistiche, diagnostiche e terapeutiche, con un focus su cardiologia, radiologia, oncologia, terapia intensiva ed endoscopia. L'azienda mantiene una presenza globale con oltre 800 professionisti di vendita e supporto clinico e circa 7.300 dipendenti in tutto il mondo.
Merit Medical Systems (NASDAQ: MMSI) ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 el 24 de abril de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica para inversores el mismo día a las 5:00 p.m., hora del Este.
Fundada en 1987, Merit Medical Systems es un fabricante y comercializador global de dispositivos médicos patentados utilizados en procedimientos intervencionistas, diagnósticos y terapéuticos, con un enfoque en cardiología, radiología, oncología, cuidados críticos y endoscopia. La empresa mantiene una presencia global con más de 800 profesionales de ventas y soporte clínico y aproximadamente 7,300 empleados en todo el mundo.
Merit Medical Systems (NASDAQ: MMSI)는 2025년 4월 24일에 시장 마감 후 2025년 1분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오후 5시에 투자자 컨퍼런스 콜을 개최할 예정입니다.
1987년에 설립된 Merit Medical Systems는 심장학, 방사선학, 종양학, 중환자 치료 및 내시경에 중점을 두고 인터벤션, 진단 및 치료 절차에 사용되는 독점 의료 기기의 글로벌 제조업체이자 마케팅 회사입니다. 이 회사는 800명 이상의 영업 및 임상 지원 전문가와 전 세계적으로 약 7,300명의 직원을 보유하고 있습니다.
Merit Medical Systems (NASDAQ: MMSI) a annoncé qu'elle publiera ses résultats financiers du premier trimestre 2025 le 24 avril 2025, après la fermeture des marchés. La société organisera une conférence téléphonique pour les investisseurs le même jour à 17h00, heure de l'Est.
Fondée en 1987, Merit Medical Systems est un fabricant et un commercialisateur mondial de dispositifs médicaux propriétaires utilisés dans des procédures interventionnelles, diagnostiques et thérapeutiques, avec un accent sur la cardiologie, la radiologie, l'oncologie, les soins intensifs et l'endoscopie. L'entreprise maintient une présence mondiale avec plus de 800 professionnels de la vente et du soutien clinique et environ 7 300 employés dans le monde.
Merit Medical Systems (NASDAQ: MMSI) hat angekündigt, dass die Finanzzahlen für das erste Quartal 2025 am 24. April 2025 nach Börsenschluss veröffentlicht werden. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz für Investoren abhalten.
Gegründet im Jahr 1987, ist Merit Medical Systems ein globaler Hersteller und Vermarkter von proprietären medizinischen Geräten, die in interventionellen, diagnostischen und therapeutischen Verfahren eingesetzt werden, mit einem Fokus auf Kardiologie, Radiologie, Onkologie, Intensivmedizin und Endoskopie. Das Unternehmen hat eine globale Präsenz mit über 800 Vertriebs- und klinischen Supportmitarbeitern und etwa 7.300 Mitarbeitern weltweit.
- None.
- None.
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2025, after the close of the stock market on Thursday, April 24, 2025. Merit plans to hold its investor conference call on the same day (Thursday, April 24, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).
To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,300 people worldwide.
| Contacts: | |
| PR/Media Inquiries: Sarah Comstock Merit Medical +1-801-432-2864 sarah.comstock@merit.com | Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare +1-443-213-0509 mike.piccinino@icrhealthcare.com |
FAQ
When will Merit Medical Systems (MMSI) report Q1 2025 earnings?
How can investors access Merit Medical's (MMSI) Q1 2025 earnings call?
What is Merit Medical Systems' (MMSI) global workforce size?
What medical sectors does Merit Medical Systems (MMSI) operate in?
